These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 12875749)

  • 21. Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation.
    Andrade JG; Wells GA; Deyell MW; Bennett M; Essebag V; Champagne J; Roux JF; Yung D; Skanes A; Khaykin Y; Morillo C; Jolly U; Novak P; Lockwood E; Amit G; Angaran P; Sapp J; Wardell S; Lauck S; Macle L; Verma A;
    N Engl J Med; 2021 Jan; 384(4):305-315. PubMed ID: 33197159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low left atrial appendage flow velocity predicts recurrence of atrial fibrillation after catheter ablation of persistent atrial fibrillation.
    Kanda T; Masuda M; Sunaga A; Fujita M; Iida O; Okamoto S; Ishihara T; Watanabe T; Takahara M; Sakata Y; Uematsu M
    J Cardiol; 2015 Nov; 66(5):377-81. PubMed ID: 25982670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary vein ablation for idiopathic atrial fibrillation: six month outcome of first procedure in 100 consecutive patients.
    Bourke JP; Dunuwille A; O'Donnell D; Jamieson S; Furniss SS
    Heart; 2005 Jan; 91(1):51-7. PubMed ID: 15604335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of sinus rhythm as endpoint of persistent atrial fibrillation ablation.
    Ammar S; Hessling G; Reents T; Paulik M; Fichtner S; Schön P; Dillier R; Kathan S; Jilek C; Kolb C; Haller B; Deisenhofer I
    J Cardiovasc Electrophysiol; 2013 Apr; 24(4):388-95. PubMed ID: 23252615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of left atrial ablation on the quality of life in patients with atrial fibrillation.
    Miyazaki S; Kuwahara T; Takahashi A; Kobori A; Takahashi Y; Nozato T; Hikita H; Sato A; Aonuma K; Hirao K; Isobe M
    Circ J; 2008 Apr; 72(4):582-7. PubMed ID: 18362429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized Study of Persistent Atrial Fibrillation Ablation: Ablate in Sinus Rhythm Versus Ablate Complex-Fractionated Atrial Electrograms in Atrial Fibrillation.
    Bassiouny M; Saliba W; Hussein A; Rickard J; Diab M; Aman W; Dresing T; Callahan T; Bhargava M; Martin DO; Shao M; Baranowski B; Tarakji K; Tchou PJ; Hakim A; Kanj M; Lindsay B; Wazni O
    Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003596. PubMed ID: 26857909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is pursuit of termination of atrial fibrillation during catheter ablation of great value in patients with longstanding persistent atrial fibrillation?
    Park YM; Choi JI; Lim HE; Park SW; Kim YH
    J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1051-8. PubMed ID: 22882600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: insights from the multicenter Sustained Treatment of Paroxysmal Atrial Fibrillation (STOP AF) Trial.
    Andrade JG; Khairy P; Macle L; Packer DL; Lehmann JW; Holcomb RG; Ruskin JN; Dubuc M
    Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):69-75. PubMed ID: 24446022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation: The CAPTAF Randomized Clinical Trial.
    Blomström-Lundqvist C; Gizurarson S; Schwieler J; Jensen SM; Bergfeldt L; Kennebäck G; Rubulis A; Malmborg H; Raatikainen P; Lönnerholm S; Höglund N; Mörtsell D
    JAMA; 2019 Mar; 321(11):1059-1068. PubMed ID: 30874754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal rhythm-control strategy for recurrent atrial tachycardia after catheter ablation of persistent atrial fibrillation: a randomized clinical trial.
    Zhang XD; Gu J; Jiang WF; Zhao L; Zhou L; Wang YL; Liu YG; Liu X
    Eur Heart J; 2014 May; 35(20):1327-34. PubMed ID: 24497338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary veins to left atrium cycle length gradient predicts procedural and clinical outcomes of persistent atrial fibrillation ablation.
    Pascale P; Shah AJ; Roten L; Scherr D; Komatsu Y; Ramoul K; Daly M; Denis A; Derval N; Sacher F; Hocini M; Jaïs P; Haïssaguerre M
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):473-82. PubMed ID: 24829252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial.
    Packer DL; Kowal RC; Wheelan KR; Irwin JM; Champagne J; Guerra PG; Dubuc M; Reddy V; Nelson L; Holcomb RG; Lehmann JW; Ruskin JN;
    J Am Coll Cardiol; 2013 Apr; 61(16):1713-23. PubMed ID: 23500312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and electrophysiological characterization of early left atrial structural remodeling as a predictor for atrial fibrillation recurrence after pulmonary vein isolation.
    Yagishita A; Sparano D; Cakulev I; Gimbel JR; Phelan T; Mustafa H; De Oliveira S; Mackall J; Arruda M
    J Cardiovasc Electrophysiol; 2017 Jun; 28(6):642-650. PubMed ID: 28387462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catheter ablation of paroxysmal atrial fibrillation: circumferential pulmonary vein ablation: success rates with and without exclusion of areas adjacent to the esophagus.
    Kettering K; Yim DH; Benz A; Gramley F
    Clin Res Cardiol; 2017 Sep; 106(9):743-751. PubMed ID: 28492985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression of atrial fibrillation after a failed initial ablation procedure in patients with paroxysmal atrial fibrillation: a randomized comparison of drug therapy versus reablation.
    Pokushalov E; Romanov A; De Melis M; Artyomenko S; Baranova V; Losik D; Bairamova S; Karaskov A; Mittal S; Steinberg JS
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):754-60. PubMed ID: 23748210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symptomatic and asymptomatic atrial fibrillation after pulmonary vein ablation and the impact on quality of life.
    Pontoppidan J; Nielsen JC; Poulsen SH; Hansen PS
    Pacing Clin Electrophysiol; 2009 Jun; 32(6):717-26. PubMed ID: 19545333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of catheter ablation of focal sources in persistent atrial fibrillation.
    Takahashi Y; Yamashita S; Suzuki M; Yabe K; Hirao K
    J Cardiovasc Electrophysiol; 2018 Apr; 29(4):559-565. PubMed ID: 29315991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PulmOnary vein isolation With vs. without continued antiarrhythmic Drug trEatment in subjects with Recurrent Atrial Fibrillation (POWDER AF): results from a multicentre randomized trial.
    Duytschaever M; Demolder A; Phlips T; Sarkozy A; El Haddad M; Taghji P; Knecht S; Tavernier R; Vandekerckhove Y; De Potter T
    Eur Heart J; 2018 Apr; 39(16):1429-1437. PubMed ID: 29211857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of catheter ablation of atrial fibrillation on long-term clinical outcomes in patients with heart failure.
    Ichijo S; Miyazaki S; Kusa S; Nakamura H; Hachiya H; Kajiyama T; Iesaka Y
    J Cardiol; 2018 Sep; 72(3):240-246. PubMed ID: 29609877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.